SCHEMBL7500196

SCHEMBL7500196

Nc1ccnc(CCl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28040587 0.83 ASIC3 (0.38)
SCHEMBL2643200 0.79
SCHEMBL694797 0.77
SCHEMBL12844666 0.77
SCHEMBL2826538 0.77
SCHEMBL7672646 0.77
SCHEMBL30808849 0.77
SCHEMBL511705 0.76 LOXL2 (0.40)
Hydrochloric Acid SCHEMBL4011953 0.76 POLB (0.52)
SCHEMBL29774155 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102639152-B Manganic chelates and the purposes as contrast agent in nuclear magnetic resonance (MRI) thereof GE HEALTHCARE A/S (NO) 2015-11-25 CN disclosed
US-6440993-B1 IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION 2002-08-27 US disclosed
EP-1121360-A4 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2002-01-23 EP disclosed
EP-1121360-A1 IL-8 RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2001-08-08 EP disclosed
WO-2000021963-A1 IL-8 RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-04-20 WO disclosed
US-4665073-A HISTAMINE H2-ANTAGONISTS ICI AMERICAS INC. (GB) 1987-05-12 US disclosed